BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Jan. 11, 2006
View Archived Issues
Symphogen Gets $25M, As Antibody Products Progress
Symphogen A/S raised $25 million in a Series D funding that attracted one new investor. (BioWorld International)
Read More
GW Pharma Bringing Cannabis Drug To U.S. For Phase III Work
Read More
Seoul University Confirms Stem Cell Work As Fraud
Read More
Finnish Institute Gets EUR3M For GMP-Grade Stem Cells
Read More
Avidex Gets £5M From Syngenta; Firms Agree To Work On Allergy
Read More
Industry Sees Risks In New European Regulatory Tools
Read More
LibraGen Initiates Agreement With Pierre Fabre Médicament
Read More
Other News To Note
Read More